Abstract
Purpose
Salvage surgery is still the best therapeutic option for resectable recurrent oropharyngeal squamous cell carcinoma (rOPSCC). Transoral robotic surgery may potentially reduce the morbidity of standard open approaches. The aim of the study is to present oncological and functional outcomes of a monocentric experience in salvage transoral robotic surgery.
Methods
We performed a single-center retrospective analysis of patients submitted to transoral robotic salvage surgery with or without neck dissection for cT1-3 rOPSCC. We investigated complication rate, survival outcomes (Overall Survival, Disease Specific Survival, Loco-Regional Recurrence Free Survival) and functional outcomes (tracheal tube and/or gastrostomy dependence).
Results
Sixty-one patients were included in the analysis. No major complications or perioperative deaths were recorded. The estimated 2-year OS was 76.7%, DSS 81.8% and LRRFS 50.5%. In multivariable analysis rpT, PNI (perineural infiltration) and HPV-positivity were significantly associated with LRRFS (Hazard Ratios: T3 vs T1 6.43, PNI yes vs no 4.19, HPV+ yes vs no 2.63). At last follow up, 97% of patients were tracheal tube-free, while 93% were gastrostomy-free.
Conclusion
Transoral robotic salvage surgery is a successful treatment in selected patients affected by rOPSCC because it grants good oncologic and functional outcomes.
Similar content being viewed by others
Data availability
Data available on request due to privacy/ethical restrictions.
References
Elrefaey S, Massaro MA, Chiocca S, Chiesa F, Ansarin M (2014) HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Italy. 34(5):299–309
Zhang Y, Fakhry C, Duza G (2021) Projected association of human papillomavirus vaccination with oropharynx cancer incidence in the US, 2020–2045. JAMA Oncol. 7(10):e212907. https://doi.org/10.1001/jamaoncol.2021.2907
Xu L, Dahlstrom KR, Lairson DR, Sturgis EM (2019) Projected oropharyngeal carcinoma incidence among middle-aged US men. Head Neck. 41(9):3226–3234. https://doi.org/10.1002/hed.25810
Schuman A, Anderson KS, Day AT, Ferrell J, Sturgis EM, Dahlstrom KR (2022) Is 2045 the best we can do? Mitigating the HPV-related oropharyngeal cancer epidemic. Expert Rev Anticancer Ther. 22(7):751–761. https://doi.org/10.1080/14737140.2022.2088514
Dowthwaite S, Jackson J, Dzienis M, Khoo E, Cronin M, Guazzo E (2023) Management of recurrent HPV-positive oropharyngeal squamous cell carcinoma: a contemporary review. Curr Oncol Rep. 25(5):501–510. https://doi.org/10.1007/s11912-023-01386-5
Lupato V, Giacomarra V, Alfieri S, Fanetti G, Polesel J (2022) Prognostic factors in salvage surgery for recurrent head and neck cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 169:103550. https://doi.org/10.1016/j.critrevonc.2021.103550
Baskin RM, Boyce BJ, Amdur R et al (2018) Transoral robotic surgery for oropharyngeal cancer: patient selection and special considerations. Cancer Manag Res. 10:839–846. https://doi.org/10.2147/CMAR.S118891
Bossi P, Alfieri S, Strojan P et al (2019) Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: a review of the literature. Crit Rev Oncol Hematol. 137:84–91. https://doi.org/10.1016/j.critrevonc.2019.01.018
Kreinbrink PJ, Lewis LM, Redmond KP, Takiar V (2022) Reirradiation of recurrent and second primary cancers of the head and neck: a review of the contemporary evidence. Curr Treat Options Oncol. 23(3):295–310. https://doi.org/10.1007/s11864-021-00936-y
Burtness B, Harrington KJ, Greil R et al (2019) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet. 394(10212):1915–1928. https://doi.org/10.1016/S0140-6736(19)32591-7
Zafereo M (2014) Surgical salvage of recurrent cancer of the head and neck. Curr Oncol Rep. 16(5):386. https://doi.org/10.1007/s11912-014-0386-0
Agra IM, Carvalho AL, Pontes E et al (2003) Postoperative complications after en bloc salvage surgery for head and neck cancer. Arch Otolaryngol Head Neck Surg. 129(12):1317–21. https://doi.org/10.1001/archotol.129.12.1317
Hamoir M, Schmitz S, Suarez C et al (2018) The current role of salvage surgery in recurrent head and neck squamous cell carcinoma. Cancers (Basel). 10(8):10080267. https://doi.org/10.3390/cancers10080267
Lee SC, Shores CG, Weissler MC (2008) Salvage surgery after failed primary concomitant chemoradiation. Curr Opin Otolaryngol Head Neck Surg. 16(2):135–40. https://doi.org/10.1097/MOO.0b013e3282f495b6
Clayburgh DR, Gross N (2013) Surgical innovations. Otolaryngol Clin North Am. 46(4):615–28. https://doi.org/10.1016/j.otc.2013.04.003
Patel SN, Cohen MA, Givi B et al (2016) Salvage surgery for locally recurrent oropharyngeal cancer. Head Neck. 38(Suppl 1):E658-64. https://doi.org/10.1002/hed.24065
Kostrzewa JP, Lancaster WP, Iseli TA, Desmond RA, Carroll WR, Rosenthal EL (2010) Outcomes of salvage surgery with free flap reconstruction for recurrent oral and oropharyngeal cancer. Laryngoscope. 120(2):267–72. https://doi.org/10.1002/lary.20743
Dean NR, Rosenthal EL, Carroll WR et al (2010) Robotic-assisted surgery for primary or recurrent oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 136(4):380–4. https://doi.org/10.1001/archoto.2010.40
Williamson A, Jashek-Ahmed F, Hardman J, Paleri V (2023) Functional and quality-of-life outcomes following salvage surgery for recurrent squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-023-08056-z
Goodwin WJ (2000) Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope. 110(3 Pt 2 Suppl 93):1–18. https://doi.org/10.1097/00005537-200003001-00001
White H, Ford S, Bush B et al (2013) Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches. JAMA Otolaryngol Head Neck Surg. 139(8):773–8. https://doi.org/10.1001/jamaoto.2013.3866
Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC (2008) Transoral laser microsurgery for recurrent laryngeal and pharyngeal cancer. Otolaryngol Head Neck Surg. 138(5):606–13. https://doi.org/10.1016/j.otohns.2007.12.046
van Weert S, Leemans CR (2021) Salvage surgery in head and neck cancer. Oral Dis. 27(1):117–124. https://doi.org/10.1111/odi.13582
Edge SB (2010) AJCC cancer staging manual. Springer, Berlin
Gross ND, Hanna EY (2017) The role of surgery in the management of recurrent oropharyngeal cancer. Recent Results Cancer Res. 206:197–205. https://doi.org/10.1007/978-3-319-43580-0_15
Giger R, Fink R, Demattè M, Visini M, Elicin O, Anschuetz L (2021) Outcome of salvage therapy in isolated regional recurrence in head and neck squamous cell carcinoma. Laryngoscope. 131(1):67–72. https://doi.org/10.1002/lary.28550
Zafereo ME, Hanasono MM, Rosenthal DI et al (2009) The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer. 115(24):5723–33. https://doi.org/10.1002/cncr.24595
Bachar GY, Goh C, Goldstein DP, O’Sullivan B, Irish JC (2010) Long-term outcome analysis after surgical salvage for recurrent tonsil carcinoma following radical radiotherapy. Eur Arch Otorhinolaryngol. 267(2):295–301. https://doi.org/10.1007/s00405-009-1070-0
Ihara Y, Crary MA, Madhavan A et al (2018) Dysphagia and oral morbidities in chemoradiation-treated head and neck cancer patients. Dysphagia. 33(6):739–748. https://doi.org/10.1007/s00455-018-9895-6
Agra IM, Carvalho AL, Ulbrich FS et al (2006) Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck. 28(2):107–13. https://doi.org/10.1002/hed.20309
Hardman J, Liu Z, Brady G et al (2020) Transoral robotic surgery for recurrent cancers of the upper aerodigestive tract—systematic review and meta-analysis. Head Neck. 42(5):1089–1104. https://doi.org/10.1002/hed.26100
Hardman JC, Holsinger FC, Brady GC et al (2022) Transoral robotic surgery for recurrent tumors of the upper aerodigestive tract (RECUT): an international cohort study. J Natl Cancer Inst. 114(10):1400–1409. https://doi.org/10.1093/jnci/djac130
U.S. Department of Health and Human Services, Food and Drug Administration, Oncology Center of Excellence (2018) Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics Guidance for Industry. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-trial-endpoints-approval-cancer-drugs-and-biologics. Accessed 16 Oct 2023
Dabas S, Dewan A, Ranjan R, Dewan AK, Shukla H, Sinha R (2015) Salvage transoral robotic surgery for recurrent or residual head and neck squamous cell carcinoma: a single institution experience. Asian Pac J Cancer Prev. 16(17):7627–32. https://doi.org/10.7314/apjcp.2015.16.17.7627
Asairinachan A, O’Duffy F, Fua T, Magarey MJR, Dixon BJ (2021) Salvage transoral robotic surgery in early-stage oropharyngeal recurrence. Oral Surg Oral Med Oral Pathol Oral Radiol. 132(1):18–25. https://doi.org/10.1016/j.oooo.2021.01.013
Guo T, Kang SY, Cohen EEW (2022) Current perspectives on recurrent HPV-mediated oropharyngeal cancer. Front Oncol. 12:966899. https://doi.org/10.3389/fonc.2022.966899
Gorphe F, Simon C (2019) A systematic review and meta-analysis of margins in transoral surgery for oropharyngeal carcinoma. Oral Oncol. 98:69–77. https://doi.org/10.1016/j.oraloncology.2019.09.017
Fakhry C, Zhang Q, Nguyen-Tan PF et al (2014) Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol. 32(30):3365–73. https://doi.org/10.1200/JCO.2014.55.1937
Jayaram SC, Muzaffar SJ, Ahmed I, Dhanda J, Paleri V, Mehanna H (2016) Efficacy, outcomes, and complication rates of different surgical and nonsurgical treatment modalities for recurrent/residual oropharyngeal carcinoma: a systematic review and meta-analysis. Head Neck. 38(12):1855–1861. https://doi.org/10.1002/hed.24531
Meulemans J, Vanclooster C, Vauterin T et al (2017) Up-front and Salvage transoral robotic surgery for head and neck cancer: a Belgian multicenter retrospective case series. Front Oncol. 7:15. https://doi.org/10.3389/fonc.2017.00015
Paleri V, Fox H, Coward S et al (2018) Transoral robotic surgery for residual and recurrent oropharyngeal cancers: exploratory study of surgical innovation using the IDEAL framework for early-phase surgical studies. Head Neck. 40(3):512–525. https://doi.org/10.1002/hed.25032
Funding
This work was partially supported by the Italian Ministry of Health with Ricerca Corrente and 5 × 1000 funds.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None declared.
Informed consent
Informed consent to research was obtained from all patients included.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ansarin, M., Pietrobon, G., Tagliabue, M. et al. Salvage transoral robotic surgery in recurrent oropharyngeal carcinoma: a single-center retrospective study. Eur Arch Otorhinolaryngol (2024). https://doi.org/10.1007/s00405-024-08590-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00405-024-08590-4